BioXcel Therapeutics
BTAI
$1.18
Share price
-0.84%
Change (1 day)
-93.26%
Change (1 year)
Categories
Earnings for BioXcel Therapeutics (BTAI)
Earnings in 2023 (TTM): -$0.17 B
According to BioXcel Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.14 B. In 2022 the company made an earning of -$0.16 B a decrease over its 2021 earnings that were of -$0.11 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for BioXcel Therapeutics from 2017 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.17 B | 5.94% |
| 2022 | -$0.16 B | 46.34% |
| 2021 | -$0.11 B | 30.14% |
| 2020 | -$82.15 M | 145.44% |
| 2019 | -$33.47 M | 67.65% |
| 2018 | -$19.97 M | 339.98% |
| 2017 | -$4.54 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -18.21% | 🇺🇸 USA |